TruScreen Group Limited (ASX:TRU)

Market Cap	11.48M -14.7%
Revenue (ttm)	1.60M -32.0%
Net Income	-2.16M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,621,943
Average Volume	423,548
Open	0.0210
Previous Close	0.0160
Day's Range	0.0180 - 0.0250
52-Week Range	0.0120 - 0.0330
Beta	-0.13
RSI	55.33
Earnings Date	Feb 27, 2026

About TruScreen Group

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. TruScreen Group Limited was incorporated in...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Country: New Zealand
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: TRU

Financial Performance

In fiscal year 2025, TruScreen Group's revenue was 2.07 million, a decrease of -20.28% compared to the previous year's 2.60 million. Losses were -2.24 million, 9.41% more than in 2024.

Financial numbers in NZD